Published in Cancer Weekly, July 3rd, 2001
The therapy, known as percutaneous radiofrequency ablation, uses a guided needle to apply energy to the inner core of tumors heating and destroying the cancer cells. Physicians sometimes use the treatment on patients with inoperable primary liver cancers who may be awaiting donor livers to become available for transplantation.
Josep M. Llovet, University of Barcelona, and other investigators associated with the Barcelona Clinic Liver Cancer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.